Navigation Links
QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
Date:9/24/2008

Separate survey shows high prevalence of "bothersome" vaginal atrophy symptoms among sexually active and non-sexually active postmenopausal women; results presented today at 19th Annual North American Menopause

Society Meeting

ANN ARBOR, Mich., Sept. 24 /PRNewswire/ -- Additional results of a Phase 3 study for Ophena(TM) (ospemifene tablets) for the treatment of symptoms of vulvovaginal atrophy (VVA) in postmenopausal women showed that Ophena(TM) significantly improves a broad range of clinical signs of vulvovaginal atrophy, including petechiae, pallor, friability, vaginal dryness and redness in mucosa. These are all visual observations of VVA assessed during gynecological examination and were pre-defined secondary endpoints in the study. Results were announced today by QuatRx Pharmaceuticals in a poster presentation at the 19th Annual North American Menopause Society meeting in Orlando, Florida.

Vulvovaginal atrophy is a common and progressive condition associated with menopause. Earlier this year, QuatRx announced a Phase 3 study for Ophena(TM) met all four of its co-primary endpoints. The results of the study showed statistically significant improvements in vaginal dryness and dyspareunia (painful intercourse), two of the most bothersome symptoms associated with VVA. The study also demonstrated favorable effects of Ophena(TM) on vaginal wall health as compared to placebo, measured as changes in the proportion of parabasal and superficial cells in the vaginal epithelium, as well as a favorable effect on vaginal pH levels.

The multi-center, double-blind, placebo-controlled study was conducted at 80 U.S. centers and involved 826 postmenopausal women. The additional results announced today showed that after 12 weeks of treatment, the mean scores for common clinical signs of vaginal atrophy were decreased by a statistically significant margin in the Ophena(TM) groups when compared with placebo. These pos
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome
2. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
3. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
4. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
5. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
8. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
9. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
10. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
11. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015  Based ... market, Frost & Sullivan recognizes Lexmark Healthcare ... Sullivan Award for Company of the Year in ... take HCM to the next level of interoperability ... acquisitions and followed them up with large-scale product ...
(Date:5/28/2015)... SAN DIEGO , May 28, 2015 ... company, and the Clinic for Special Children today announced ... will be utilized for the diagnosis of rare genetic ... Strasburg, Pennsylvania , the Clinic for Special Children ... population with a relatively high incidence of genetic disease. ...
(Date:5/28/2015)... , May 28, 2015  Freedom Meditech, Inc., a ... chronic diseases from current blood-based standards to early and ... $4.8 million in a Series C financing. The company ... $14 million since founded. The company has also appointed ... and a member of the company,s board of directors. ...
Breaking Medicine Technology:Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 2Cypher Genomics and Clinic for Special Children Collaborate on Rare Disease Study 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4
... 2010 Biovista,announced today the appointment of Mr. Clifford H. Farrah ... , , ... to have Cliff join our Advisory Board," said Aris,Persidis, President of Biovista. "Cliff ... that will be,invaluable to us as we grow Biovista," he added. , ...
... AGAWAM, Mass. , July 13 A new free, ... of applying new U.S. Food and Drug Administration (FDA) regulations to ... from Microtest Laboratories ( http://www.microtestlabs.com/combination-products-20/ ) , ... Combination products are a large and growing ...
Cached Medicine Technology:Biovista Announces the Appointment of Clifford H. Farrah to its Advisory Board 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 4
(Date:5/27/2015)... May 28, 2015 Calls Upon Individuals, Organizations ... A new nationwide initiative – a “Summer of Service” – ... and build partnerships to grow the number of individuals and ... its commitment to Veterans by inviting the community to visit ... June 29, 2015 from 1 – 3:00 p.m. in the ...
(Date:5/27/2015)... San Rafael, CA (PRWEB) May 27, 2015 ... Softball Camp director, Bree Nasti, the Adelphi University softball ... to the Divsion II Softball Championship since becoming a ... at 0-11, Adelphi University softball team turned it around ... Softball Championship. After defeating University of Central Missouri in ...
(Date:5/27/2015)... Down is a reputable source of 2015 NHL Western Conference ... middle of their series against the Anaheim Ducks with the Ducks ... can win tonight at home, this will tie up the series ... Honda Center in Anaheim. , During the regular season, the ... they won the Pacific Division by 8 points ahead of the ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... 2015 Khanna Vision Institute (KVI) announced the ... focussed on keratoconus eye disease . Keratoconus is commonly ... its onset in the teenage years. It worsens over the ... front clear part of the eye is defective. It becomes ... It results in poor vision which cannot even be corrected ...
Breaking Medicine News(10 mins):Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2
... (HealthDay News) -- Hormone levels at certain phases of the ... Researchers used MRI to study the brains of women ... pleasant, unpleasant or neutral. This test was repeated at different ... follicular stage of the menstrual cycle, no areas of the ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- Dr. Alexander Heazell ... their first child in 2001. They planned to name him Jack. ... wife,s blood pressure had shot up during the pregnancy, and at ... Losing the baby was devastating for Heazell and his wife. The ...
... and biologist Professor Cesare Montecucco, 62, of the Department ... has won the 100,000 euro Paul Ehrlich and Ludwig ... the field of bacterial diseases, including tetanus, botulism, anthrax ... by the Scientific Board of the Paul Ehrlich Foundation. ...
... scar tissue surrounding cancer tumours aims to provide new targets for ... deaths in the UK. Funded by the UK charity Pancreatic ... family of molecules present in this scar tissue - known as ... tumour growth. The project is led by surgeon and ...
... are common among the caregivers of children with a ... of a small study from the Johns Hopkins Children Center. ... researchers add. The study,s findings, published online in ... healthcare staff to do a better job in educating parents, ...
... (HealthDay News) -- Having a prostate-specific antigen (PSA) test to ... develops it will spread to other parts of the body, ... debate on whether PSA screenings actually improve survival rates or, ... that routine screening not only improves the patient,s quality of ...
Cached Medicine News:Health News:Stillbirth Can Be Devastating, Unpredictable 2Health News:Stillbirth Can Be Devastating, Unpredictable 3Health News:Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize 2Health News:Stroma may provide key to better cancer treatment 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 3Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 2Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 3
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured micro-ball tip....
... Keeler ophthalmoscopes are individually adjusted for perfect ... eye, not on paper. This, along with ... focus, ensures that whatever the patient's pupil ... largest field of view. Lithium-ion technology provides ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
Medicine Products: